Ankylosing Spondylitis


Fatigue and Pain Levels Remain High in Patients With Ankylosing Spondylitis

December 02, 2021

“Managing pain is an important treatment goal in patients with ankylosing spondylitis, however, pain is often underestimated by clinical disease activity scoring tools, and 20% to 30% of patients report pain despite treatment with TNFis,” investigators stated.

Ixekizumab Improves Symptoms for Patients With Radiographic Axial Spondyloarthritis

September 27, 2021

“Understanding the role of ixekizumab will allow physicians to translate a higher Assessment of Spondyloarthritis International Society (ASAS) achievement to the improvements in the signs and symptoms reported by their patients,” investigators stated.

Women With Axial Spondyloarthritis Have Higher Disease Burden Than Men

April 22, 2021

Investigators discovered that women with axial spondyloarthritis (axSpA) have an overall higher disease burden and more peripheral manifestations when compared with men. They further theorized that awareness of these differences and the way the condition presents differently in both sexes may be used to more easily identify axSpA and improve disease management.

Optimized Treatment Strategies in Axial Spondyloarthritis: an Unmet Need

October 06, 2020

Despite major advances in axial spondyloarthritis and an increasing number of therapeutic options, questions remain related to the optimized treatment strategies and to the individual drug choice, according to a review published in Current Rheumatology Reports.

4 Factors Associated With Ankylosing Spondylitis Progression

November 27, 2019

Nearly one-quarter of patients with ankylosing spondylitis experienced disease progression over time, with male sex, presence of baseline damage, active disease state, and higher inflammatory markers predictive of spinal progression, while treatment with tumor necrosis factor (TNF) inhibitors slowed the progression rate, say researchers recently writing in Arthritis Care & Research.